University of Wisconsin School of Medicine and Public Health
(TCAD) A Phase 2 Multi-center, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients with Mild to Moderate Alzheimer’s Disease
The PI of this project was:
This project was funded by: Toyama Chemical
The term of this project was: August 2014 to April 2016
The number of subjects scanned during this project was: 12